
    
      The aim of this study is to included 120 patients with intermediate stage hepatocellular
      carcinoma beyond Milan criteria .These patients were randomizedly allocated to TACE treatment
      group or TACE+RFA/MV .The treatment effectiveness, local tumor control and survival outcome
      between the two groups were compared.
    
  